Gene Amplification Technologies Market is valued at USD 4.30 Billion in 2021 and expected to reach USD 9.05 Billion by 2028 with a CAGR of 11.2% over the forecast period.
Increasing use of gene amplification kits in targeted cancer therapies, rising research & development in the field of genomic testing and growing technological advancements in gene amplification for Covid-19 tests are major factors anticipated to drive the growth of the Global Gene Amplification Technologies Market.
Increase in number of copies in a genome called as gene amplification. For example; cancer cells sometimes produce several copies of a gene(s) in response to signals from other cells or the environment. Gene amplification can be artificially done in a lab. For research diagnosis, recombinant DNA technology and to get the desired gene product artificial gene amplification is done. Polymerase chain reaction (PCR), Ligase chain reaction (LCR) Transcription-mediated amplification (TMA) are the several ways by which gene amplification is done. The Human Genome Project was a milestone global scientific effort whose signature goal was to generate the first sequence of the human genome.
The Covid-19 pandemic has shown significant impact on the global gene amplification technologies market. The Covid-19 caused panic amongst people and pressure on healthcare system. Thus, to stop the spread, rapid testing was required and companies also launched kits for detection of Covid-19 which positively impacted the market. For instance; on July 1st, 2021; United States Food and Drug Administration (FDA) approved Emergency Use Authorization (EUA) for their breakthrough direct sample addition Covid-19 test.
The global gene amplification technologies market is segmented into on the basis of technology, application region & country level. On the basis of technology, global gene amplification technologies market is segmented into PCR-based amplification, target amplification, signal amplification, isothermal DNA amplification cycling temperature signal gene amplification, exponential gene amplification and linear gene amplification. On the basis of application, the global gene amplification technology is segmented into paternity, whole genome amplification, exome sequencing, hybridization, medical applications, forensics, food safety, agri-diagnostics, veterinary, others.
The regions covered in global gene amplification technologies market report are North America, Europe, Asia-Pacific, Latin America and Rest of the World. On the basis of country level, the market of global gene amplification technologies market is subdivided into U.S., Mexico, Canada, U.K., France, Germany, Italy, China, India, Japan, South East Asia, Middle East Asia (UAE, Egypt, Saudi Arabia) GCC, Africa, etc.
Some of the key players for global gene amplification technologies market report covers are Agilent Technologies, Inc., bioMérieux SA, Abbott Laboratories, Bio-Rad Laboratories, Inc., F. Hoffmann-La Roche AG, Merck KGaA, PerkinElmer, Inc., QIAGEN N.V., Siemens Healthineers AG, Thermo Fisher Scientific Inc. and others.
|2018 - 2021
|2022 - 2028
|Market Size in 2021:
|USD 4.30 Billion
|Base year considered
|Forecast Period CAGR %:
|Market Size Expected in 2028:
|USD 9.05 Billion
|Tables, Charts & Figures:
|Gene Amplification Technologies Companies
|Agilent Technologies, Inc., bioMérieux SA, Abbott Laboratories, Bio-Rad Laboratories, Inc., F. Hoffmann-La Roche AG, Merck KGaA, PerkinElmer, Inc., QIAGEN N.V., Siemens Healthineers AG, Thermo Fisher Scientific Inc. and others.
|By Technology, By Application
|North America, U.S., Mexico, Canada, Europe, UK, France, Germany, Italy, Asia Pacific, China, Japan, India, Southeast Asia, South America, Brazil, Argentina, Columbia, The Middle East and Africa, GCC, Africa, Rest of the Middle East and Africa
On September 22nd, 2021; Clinical genetic exome sequencing for quite 300,000 patients announced by GeneDx, Inc. making the company's dataset the biggest of its kind within the world. The businesses market leading created a diagnosis and discovery engine advancing genetic medicine worldwide. Each kind of testing provides more complete information compared to the targeted multi-gene panels clinicians typically use to appear for genetic underpinnings of health conditions.
On July 1st, 2021; the United States Food and Drug Administration approved Emergency Use Authorization (EUA) for their breakthrough direct sample addition, Xfree Covid-19 test. Xfree COVID-19 is a whole test lyophilized in a single tube, for extraction-free, direct sample addition real-time RT-PCR testing. The Xfree Covid-19 test removes all upfront sample processing steps and enables clinical laboratories to generate high-throughput results using widely available real-time PCR platforms.
One of the major factors driving the growth of the global gene amplification technologies is the increasing use of gene amplification kits in targeted cancer therapies. Cancer is caused by mutations. Targeted cancer therapies have emerged as potential strategies for treatment of cancer. For example; amplification of the HER2 gene in results in the production of excess HER2 protein on the surface of the cancer cell and near 20% breast cancers have amplification of HER2 or have an overexpression of non-amplified HER2. After amplification the tumors can often be effectively treated with drugs that specifically target and neutralize the excess HER2 protein produced by the patient's tumor. Thus, advanced applications of gene amplification kits driving the market growth. In addition, rising research & development activities n the field of genomic testing area also supplementing the market growth. Continuous research in molecular diagnostic tools such as microarray, polymerase chain reaction (PCR), sequencing, and hybridization gives rapid result and detection various infections, chronic diseases, cancer and genetic disorders is fueling the market growth. For instance; on September 22nd, 2021; GeneDx announced the sequencing of more than 300,000 clinical patient exomes.
Moreover, growing demand of gene amplification for Covid-19 tests is also augumenting the market growth. Covid-19 caused emergency in health sector and research increased for its testing. Hence, demand of gene amplification is increased as they provide rapid results. For example; on July 1st, 2021; BioGX United States Food and Drug Administration (FDA) approved Emergency Use Authorization (EUA) for their breakthrough direct sample addition, Xfree Covid-19 test. However, high costs of these technologies may hamper the market growth. In spite of that, rising investment and increasing research and development activities in this field may provide more opportunities for the further growth of the market.
The North America is expected to dominate the global gene amplification technologies market due to the increasing popularity of molecular diagnostics for cancer, presence of major market players and highly developed healthcare infrastructure in this region. Molecular diagnostics used for cancer which is driving the market growth. Increasing prevalence of cancer is also supplementing the market growth. For instance; according to NIH (National Center Institute) there have been 1,806,590 new cases of cancer will be diagnosed in the United States in 2020. In addition, increasing investment by key players is also fostering the market growth in this region. For instance; BioLabs, Inc. launched Luna SARS-CoV-2 RT-qPCR Assay Kit for the detection of SARS-CoV-2 nucleic acid in January 2021.
Asia Pacific is expected to be fastest growing region for the global gene amplification technologies due to healthcare infrastructure, rising research activity in genomics and highly developing countries such as India and China. The healthcare infrastructure is continuously improving and which is supplementing the market growth in this region. For example; as India Brand Equity Foundation Healthcare market in India is expected to reach US$ 372 billion by 2022 due to rising income, better health awareness. In addition, rising number of R & D activities in genomics are also boosting the market growth. For instance; ultrasensitive and rapid ELISA test based on rolling circle amplification for the early detection of several diseases in April 2021.
Key Benefits of Global Gene Amplification Technologies Market Report-
We are always looking to hire talented individuals with equal and extraordinary proportions of industry expertise, problem solving ability and inclination interested? please email us firstname.lastname@example.orgJOIN US
BrandEssence® Market Research and Consulting Pvt ltd.
124, City Road, London EC1V 2NX
© Copyright 2024-25 BrandEssence® Market Research and Consulting Pvt ltd. All Rights Reserved | Designed by BrandEssence®